Efficacy and Safety Profile of Z-215 (Azeloprazole Sodium), a Proton Pump Inhibitor, Compared with Rabeprazole Sodium in Patients with Reflux Esophagitis: A Phase II, Multicenter, Randomized, Double-Blind, Comparative Study

number of downloads : ?

Use this link to cite this item : https://ir.lib.shimane-u.ac.jp/53223

language	eng
Author	Kinoshita, Yoshikazu Kusano Motoyasu Department of Endoscopy and Endoscopic Surgery, Gunma University Hospital, Gunma, Japan Iwakiri Katsuhiko Department of Gastroenterology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan Fujishiro Mitsuhiro Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan Tachikawa Naoto Clinical Research, Research & Development, Zeria Pharmaceutical Co Ltd, Tokyo, Japan Haruma Ken Department of General Internal Medicine 2, General Medical Center, Kawasaki Medical School, Okayama, Japan
Subject	azeloprazole; GERD; CYP2C19; proton pump inhibitors; rabeprazole; reflux esophagitis
Journal Title	CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
Volume	88
Start Page	26
End Page	34
ISSN	0011-393X
ISSN（Online）	1879-0313
Published Date	2018
DOI	10.1016/j.curtheres.2018.03.004
PubMed ID	30038671
Publisher	ELSEVIER SCIENCE INC
NII Type	Journal Article
OAI-PMH Set	Faculty of Medicine